Hepion Pharmaceuticals, Inc. (HEPA)
OTCMKTS · Delayed Price · Currency is USD
0.1310
+0.0087 (7.14%)
Nov 9, 2026, 3:26 PM EST
Hepion Pharmaceuticals Market Cap
Hepion Pharmaceuticals has a market cap or net worth of $12.87 million as of November 9, 2026. It is the 40,252nd most valuable company in the world and the 5,457th biggest in the United States. Its market cap has increased by 1,504.81% in one year.
Market Cap
12.87M
Enterprise Value
12.93M
Revenue
n/a
Global Rank
Country Rank
#5,457 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since February 10, 2014, Hepion Pharmaceuticals's market cap has decreased from 13.86M to 12.87M, a decrease of -7.16%. That is a compound annual growth rate of -0.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 9, 2026 | 12.87M | 1,745.53% |
| Dec 31, 2025 | 697.22K | -78.69% |
| Dec 31, 2024 | 3.27M | -76.72% |
| Dec 29, 2023 | 14.05M | -38.61% |
| Dec 30, 2022 | 22.89M | -73.66% |
| Dec 31, 2021 | 86.90M | 23.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biomind Labs | 19.41M |
| Vicapsys Life Sciences | 16.19M |
| Inhibitor Therapeutics | 13.73M |
| Synlogic | 13.47M |
| Brainstorm Cell Therapeutics | 12.83M |
| Anebulo Pharmaceuticals | 11.22M |
| NDT Pharmaceuticals | 7.51M |
| Zeo ScientifiX | 7.12M |